FMBTD
First Midwest Bank Trust Division Portfolio holdings
AUM
$777M
This Quarter Return
+1.76%
1 Year Return
+29.49%
3 Year Return
+107.1%
5 Year Return
+137.96%
10 Year Return
–
AUM
$695M
AUM Growth
+$695M
(-0.87%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
385
New
9
Increased
83
Reduced
195
Closed
18
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$13.7M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
$9.3M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$5.34M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
$5.06M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$2.69M |
Top Sells
| 1 |
Synaptics
SYNA
|
$10.4M |
| 2 |
Gogo Inc
GOGO
|
$8.49M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$7.79M |
| 4 |
Newell Brands
NWL
|
$6.24M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$3.76M |
Sector Composition
| 1 | Healthcare | 11.65% |
| 2 | Technology | 11.03% |
| 3 | Financials | 8.84% |
| 4 | Industrials | 7.88% |
| 5 | Consumer Staples | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vanguard Real Estate ETF
VNQ
$34.6B
| $1.72M | 0.25% |
18,457
+684
| +4% | +$63.8K |
|
102
CSX Corp
CSX
$60.6B
| $1.72M | 0.25% |
24,754
-500
| -2% | -$34.6K |
|
103
Deckers Outdoor
DECK
$17.7B
| $1.71M | 0.25% |
11,608
+7,465
| +180% | +$1.1M |
|
104
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $1.7M | 0.24% |
8,789
-16,389
| -65% | -$3.17M |
|
105
iShares Russell 1000 Value ETF
IWD
$63.5B
| $1.68M | 0.24% |
13,078
+10,120
| +342% | +$1.3M |
|
106
Vanguard Small-Cap ETF
VB
$66.4B
| $1.68M | 0.24% |
10,884
+4,788
| +79% | +$737K |
|
107
Thermo Fisher Scientific
TMO
$186B
| $1.66M | 0.24% |
5,692
-24
| -0.4% | -$6.99K |
|
108
iShares S&P 500 Growth ETF
IVW
$63.1B
| $1.65M | 0.24% |
9,173
+2,300
| +33% | +$414K |
|
109
Realty Income
O
$53.7B
| $1.65M | 0.24% |
21,515
-668
| -3% | -$51.2K |
|
110
KLA
KLAC
$115B
| $1.63M | 0.23% |
10,210
-565
| -5% | -$90.1K |
|
111
Invesco S&P 500 Equal Weight ETF
RSP
$74.2B
| $1.63M | 0.23% |
15,035
| – | – |
|
112
Oracle
ORCL
$635B
| $1.6M | 0.23% |
29,011
+1,531
| +6% | +$84.3K |
|
113
Tyson Foods
TSN
$20.2B
| $1.54M | 0.22% |
17,900
+671
| +4% | +$57.8K |
|
|
CELG
114
DELISTED
Celgene Corp
CELG
| $1.53M | 0.22% |
15,411
-481
| -3% | -$47.8K |
|
115
Wells Fargo
WFC
$263B
| $1.5M | 0.22% |
29,807
-261
| -0.9% | -$13.2K |
|
116
Gilead Sciences
GILD
$140B
| $1.49M | 0.21% |
23,472
+3,200
| +16% | +$203K |
|
117
Global Payments
GPN
$21.5B
| $1.48M | 0.21% |
9,297
+7,811
| +526% | +$1.24M |
|
118
Philip Morris
PM
$260B
| $1.47M | 0.21% |
19,330
-3,013
| -13% | -$229K |
|
119
Sempra
SRE
$53.9B
| $1.45M | 0.21% |
9,814
-1,795
| -15% | -$265K |
|
120
Nucor
NUE
$34.1B
| $1.43M | 0.21% |
28,167
-616
| -2% | -$31.4K |
|
121
Amgen
AMGN
$155B
| $1.42M | 0.2% |
7,349
-342
| -4% | -$66.2K |
|
122
Becton Dickinson
BDX
$55.3B
| $1.42M | 0.2% |
5,620
-84
| -1% | -$21.3K |
|
123
Meta Platforms (Facebook)
META
$1.86T
| $1.42M | 0.2% |
7,972
-1,250
| -14% | -$223K |
|
124
Bristol-Myers Squibb
BMY
$96B
| $1.41M | 0.2% |
27,734
+2,999
| +12% | +$152K |
|
125
Southern Company
SO
$102B
| $1.38M | 0.2% |
22,312
-351
| -2% | -$21.7K |
|